1. |
Salari P, Nikfar S, Abdollahi M. Current opinion on treatment of inflammatory bowel disease in pregnant women. Arch Med Sci, 2012, 8(6): 983-986.
|
2. |
Druvefors E, Landerholm K, Hammar U, et al. Impaired fertility in women with inflammatory bowel disease: a national cohort study from Sweden. J Crohns Colitis, 2020, 19: jjaa191.
|
3. |
Jølving LR, Nielsen J, Beck-Nielsen SS, et al. The association between maternal chronic inflammatory bowel disease and long-term health outcomes in children-a nationwide cohort study. Inflamm Bowel Dis, 2017, 23(8): 1440-1446.
|
4. |
Elten M, Benchimol EI, Fell DB, et al. Ambient air pollution and the risk of pediatric-onset inflammatory bowel disease: a population-based cohort study. Environ Int, 2020, 138: 105676.
|
5. |
谭蓓, 钱家鸣. 炎症性肠病妊娠期管理与治疗. 中国实用内科杂志, 2018, 38(3): 200-203.
|
6. |
戴萌, 金雷, 熊毅敏, 等. 炎症性肠病患者的妊娠相关问题. 世界华人消化杂志, 2016, 24(3): 382-389.
|
7. |
Ørding Olsen K, Juul S, Berndtsson I, et al. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology, 2002, 122(1): 15-19.
|
8. |
Moscandrew M, Kane S. Inflammatory bowel diseases and management considerations: fertility and pregnancy. Curr Gastroenterol Rep, 2009, 11(5): 395-399.
|
9. |
Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis, 2007, 13(5): 591-599.
|
10. |
Ali MF, He H, Friedel D. Inflammatory bowel disease and pregnancy: fertility, complications and treatment. Ann Gastroenterol, 2020, 33(6): 579-590.
|
11. |
Bell SJ, Flanagan EK. Updates in the management of inflammatory bowel disease during pregnancy. Med J Aust, 2019, 210(6): 276-280.
|
12. |
Heetun ZS, Byrnes C, Neary P, et al. Review article: reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther, 2007, 26(4): 513-533.
|
13. |
中华医学会消化病学分会炎症性肠病学组. 炎症性肠病妊娠期管理的专家共识意见. 协和医学杂志, 2019, 10(5): 465-475.
|
14. |
Perez-Garcia LF, Dolhain RJEM, Vorstenbosch S, et al. The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review. Hum Reprod Update, 2020, 26(6): 961-1001.
|
15. |
Peng X, Zhi M, Wei M, et al. Thalidomide results in diminished ovarian reserve in reproductive age female IBD patients. Medicine (Baltimore), 2017, 96(21): e6540.
|
16. |
Grosen A, Kelsen J, Hvas CL, et al. The influence of methotrexate treatment on male fertility and pregnancy outcome after paternal exposure. Inflamm Bowel Dis, 2017, 23(4): 561-569.
|
17. |
Shannahan SE, Erlich JM, Peppercorn MA. Insights into the treatment of inflammatory bowel disease in pregnancy. Therap Adv Gastroenterol, 2019, 12: 1756284819852231.
|
18. |
Rahimi R, Nikfar S, Rezaie A, et al. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol, 2008, 25(2): 271-275.
|
19. |
Marteau P, Tennenbaum R, Elefant E, et al. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther, 1998, 12(11): 1101-1108.
|
20. |
Diav-Citrin O, Park YH, Veerasuntharam G, et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology, 1998, 114(1): 23-28.
|
21. |
Mahood IK, Scott HM, Brown R, et al. In utero exposure to di(n-butyl) phthalate and testicular dysgenesis: comparison of fetal and adult end points and their dose sensitivity. Environ Health Perspect, 2007, 115(Suppl 1): 55-61.
|
22. |
Nguyen GC, Seow CH, Maxwell C, et al. The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology, 2016, 150(3): 734-757. e1.
|
23. |
Pradat P, Robert-Gnansia E, Di Tanna GL, et al. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol, 2003, 67(12): 968-970.
|
24. |
Xiao WL, Liu XY, Liu YS, et al. The relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis. Reprod Toxicol, 2017, 69: 99-105.
|
25. |
Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ, 2011, 183(7): 796-804.
|
26. |
Bay Bjørn AM, Ehrenstein V, Hundborg HH, et al. Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring. Am J Ther, 2014, 21(2): 73-80.
|
27. |
Beaulieu DB, Ananthakrishnan AN, Issa M, et al. Budesonide induction and maintenance therapy for Crohn’s disease during pregnancy. Inflamm Bowel Dis, 2009, 15(1): 25-28.
|
28. |
Saulnier PJ, Piguel X, Perault-Pochat MC, et al. Hypoglycaemic seizure and neonatal acute adrenal insufficiency after maternal exposure to prednisone during pregnancy: a case report. Eur J Pediatr, 2010, 169(6): 763-765.
|
29. |
Coelho J, Beaugerie L, Colombel JF, et al. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut, 2011, 60(2): 198-203.
|
30. |
de Meij TG, Jharap B, Kneepkens CM, et al. Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease. Aliment Pharmacol Ther, 2013, 38(1): 38-43.
|
31. |
Komoto S, Motoya S, Nishiwaki Y, et al. Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan. Intest Res, 2016, 14(2): 139-145.
|
32. |
Shihab Z, Yeomans ND, De Cruz P. Anti-tumour necrosis factor α therapies and inflammatory bowel disease pregnancy outcomes: a meta-analysis. J Crohns Colitis, 2016, 10(8): 979-88.
|
33. |
Bar-Gil Shitrit A, Grisaru-Granovsky S, Ben Ya’acov A, et al. Management of inflammatory bowel disease during pregnancy. Dig Dis Sci, 2016, 61(8): 2194-2204.
|
34. |
管丽芳, 胡博文, 孙琳, 等. 妊娠期炎症性肠病的治疗策略与动态管理. 世界华人消化杂志, 2016, 24(28): 3978-3984.
|
35. |
张修礼, 令狐恩强, 刘庆森, 等. 妊娠期炎症性肠病的处理-多伦多共识意见(2015)解读. 中华胃肠内镜电子杂志, 2016, 3(2): 49-53.
|
36. |
吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018 年·北京). 中国实用内科杂志, 2018, 38(9): 796-813.
|
37. |
王亿鹏, 谢小超, 王燕, 等. 内外兼治治疗妊娠期溃疡性结肠炎 1 例. 中国民间疗法, 2017, 25(10): 63-64.
|
38. |
Klajnbard A, Szecsi PB, Colov NP, et al. Laboratory reference intervals during pregnancy, delivery and the early postpartum period. Clin Chem Lab Med, 2010, 48(2): 237-248.
|
39. |
Flanagan E, Wright EK, Begun J, et al. Monitoring inflammatory bowel disease in pregnancy using gastrointestinal ultrasonography. J Crohns Colitis, 2020, 14(10): 1405-1412.
|
40. |
ASGE Standard of Practice Committee, Shergill AK, Ben-Menachem T, et al. Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc, 2012, 76(1): 18-24.
|
41. |
Moretti ME, Verjee Z, Ito S, et al. Breast-feeding during maternal use of azathioprine. Ann Pharmacother, 2006, 40(12): 2269-2272.
|
42. |
Cheent K, Nolan J, Shariq S, et al. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn’s disease. J Crohns Colitis, 2010, 4(5): 603-605.
|
43. |
王志斌, 陈晨, 郭一, 等. 清肠温中方治疗轻中度溃疡性结肠炎的临床研究. 中国中西医结合杂志, 2018, 38(1): 15-19.
|
44. |
郑依玲, 梅全喜, 戴卫波, 等. 妊娠禁忌中药研究概述. 中国药房, 2018, 29(3): 421-424.
|
45. |
梅全喜. 现代中药药理与临床应用手册. 3 版. 北京: 中国中医药出版社, 2016: 795, 865-868.
|